Heron Therapeutics
HRTX
HRTX
104 hedge funds and large institutions have $964M invested in Heron Therapeutics in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 100 → 104 (+4)
4.11% less ownership
Funds ownership: 133.75% → 129.64% (-4.1%)
10% less capital invested
Capital invested by funds: $1.07B → $964M (-$111M)
Holders
104
Holding in Top 10
5
Calls
$23.5M
Puts
$1.11M
Top Buyers
| 1 | +$78.1M | |
| 2 | +$14.3M | |
| 3 | +$7.9M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
+$6.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.07M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$8.72M | |
| 3 | -$8.15M | |
| 4 |
BC
Broadfin Capital
New York
|
-$7.33M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$4.34M |